Jiacai Cho

Aug 1, 2024 | jrheum.org | Rangi Kandane-Rathnayake |Worawit Louthrenoo |Yi-Hsing Chen |Jiacai Cho

Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus Vera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian J. Wu, Sandra V.

Jul 15, 2024 | ard.bmj.com | Yasuhiro Katsumata |Eisuke Inoue |Masayoshi Harigai |Jiacai Cho

DiscussionThis study of a large multinational cohort demonstrated that tapering GC was not associated with increased risk of subsequent flare in mSACQ-SLE when HRs were assessed per 1 mg decrease in prednisolone-equivalent GC dosages whereas antimalarial use and immunosuppressive use were associated with decreased flare risk in mSACQ patients. Importantly, tapering GCs protected mSACQ patients treated with >5 mg/day of prednisolone-equivalent GC against damage accrual.

Apr 24, 2024 | jrheum.org | Rangi Kandane-Rathnayake |Worawit Louthrenoo |Yi-Hsing Chen |Jiacai Cho

Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State In Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus Vera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian J. Wu, Sandra V.

Mar 10, 2024 | jrheum.org | Rangi Kandane-Rathnayake |Worawit Louthrenoo |Yi-Hsing Chen |Jiacai Cho

Comparison Of Attainment And Protective Effects Of Lupus Low Disease Activity State In Patients With Newly Diagnosed Versus Established SLE. Vera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian J. Wu, Sandra V.

Feb 29, 2024 | ard.bmj.com | Yasuhiro Katsumata |Eisuke Inoue |Masayoshi Harigai |Jiacai Cho

Handling editor Josef S SmolenTwitter @Cho Jiacai, @tuna0sashimiContributors YK and MH drafted the research proposal and protocol and wrote the first draft of the manuscript. YK and EI analysed the data. All authors except EI participated in patient recruitment and acquisition of the data. All authors were involved in drafting or revising this article critically for important intellectual content and approved the final version to be published.